Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis Nasr

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of Translational Medicine|November 7, 2024
How we manage multiple myeloma with clonal hematopoiesis of indeterminate potential (CHIP): a case reportLudovic Saba, Lewis Nasr, Jorge Manrique-Succar, et al.
Current Treatment Options in Oncology|December 12, 2022
Central Nervous System Prophylaxis and Treatment in Acute LeukemiasSusan Y Wu, Nicholas J Short, Lewis Nasr, et al.
Case Reports in Oncology|June 28, 2019
Negativation of PD-L1 Postoperatively in Initially Inoperable Stage III Non-Small Cell Lung Cancer Treated with Pembrolizumab: Two Case ReportsFadi Nasr, Ahmad Al Ghoche, Roland Eid, et al.
Leukemia Research Reports|June 18, 2021
Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective StudyFadi Nasr, Ahmad Al Ghoche, Saada Diab, et al.
International Journal of Hematologic Oncology|June 6, 2022
Adhesion molecules in multiple myeloma oncogenesis and targeted therapyMaroun Bou Zerdan, Lewis Nasr, Joseph Kassab, et al.
Cancers|August 12, 2022
A Synopsis Clonal Hematopoiesis of Indeterminate Potential in HematologyMaroun Bou Zerdan, Lewis Nasr, Ludovic Saba, et al.
Journal of Medical Virology|November 10, 2021
Impact of ABO and Rhesus blood groups on COVID-19 susceptibility and severity: A case-control studyAnthony Kerbage, Sara F Haddad, Lewis Nasr, et al.
Cancer|May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phaseFadi G Haddad, Koji Sasaki, Lewis Nasr, et al.
Frontiers in Oncology|May 25, 2023
Liquid biopsies and minimal residual disease in lymphoid malignanciesMaroun Bou Zerdan, Joseph Kassab, Ludovic Saba, et al.
Oncotarget|May 15, 2023
Systemic AL amyloidosis: current approach and future directionMaroun Bou Zerdan, Lewis Nasr, Farhan Khalid, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of Translational Medicine|November 7, 2024
How we manage multiple myeloma with clonal hematopoiesis of indeterminate potential (CHIP): a case reportLudovic Saba, Lewis Nasr, Jorge Manrique-Succar, et al.
Current Treatment Options in Oncology|December 12, 2022
Central Nervous System Prophylaxis and Treatment in Acute LeukemiasSusan Y Wu, Nicholas J Short, Lewis Nasr, et al.
Case Reports in Oncology|June 28, 2019
Negativation of PD-L1 Postoperatively in Initially Inoperable Stage III Non-Small Cell Lung Cancer Treated with Pembrolizumab: Two Case ReportsFadi Nasr, Ahmad Al Ghoche, Roland Eid, et al.
Leukemia Research Reports|June 18, 2021
Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective StudyFadi Nasr, Ahmad Al Ghoche, Saada Diab, et al.
International Journal of Hematologic Oncology|June 6, 2022
Adhesion molecules in multiple myeloma oncogenesis and targeted therapyMaroun Bou Zerdan, Lewis Nasr, Joseph Kassab, et al.
Cancers|August 12, 2022
A Synopsis Clonal Hematopoiesis of Indeterminate Potential in HematologyMaroun Bou Zerdan, Lewis Nasr, Ludovic Saba, et al.
Journal of Medical Virology|November 10, 2021
Impact of ABO and Rhesus blood groups on COVID-19 susceptibility and severity: A case-control studyAnthony Kerbage, Sara F Haddad, Lewis Nasr, et al.
Cancer|May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phaseFadi G Haddad, Koji Sasaki, Lewis Nasr, et al.
Frontiers in Oncology|May 25, 2023
Liquid biopsies and minimal residual disease in lymphoid malignanciesMaroun Bou Zerdan, Joseph Kassab, Ludovic Saba, et al.
Oncotarget|May 15, 2023
Systemic AL amyloidosis: current approach and future directionMaroun Bou Zerdan, Lewis Nasr, Farhan Khalid, et al.
Pageof 2